Skip to content

Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China

Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03245632
Enrollment
800
Registered
2017-08-10
Start date
2017-08-31
Completion date
2019-12-31
Last updated
2017-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Klebsiella Pneumoniae Infection

Brief summary

Klebsiella pneumoniae is one of the most common pathogens causing nosocomial infection. Recently, the emergency of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) had cause the clinical therapy be very difficult. However, there is not much empirical data as to the prevalence, risk factors, characteristics, and the rationality of the current therapy for the CRKP infection. Thus, the study was aimed to investigate the epidemiology and risk factors, characteristics, and the rationality of the current therapy for the CRKP infection.

Detailed description

All the patients with culture positive of Klebsiella pneumoniae were screened and reported to the the clinical doctors and confirmed by them. And the clinical characteristics of the patiens, such as baseline data, outcomes etc, were recorded. Finially, to find the prevalence, risk factors, characteristics, and the rationality of the current therapy for the CRKP infection

Interventions

OTHERCarbapenem-Resistant Klebsiella pneumoniae

no intervention, this is an obervational study.

Sponsors

Sir Run Run Shaw Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* new confirmed noscomial infection of CRKP

Exclusion criteria

* Age\<18, or \>85 years old; Mixed infection of CRKP and other microbes

Design outcomes

Primary

MeasureTime frameDescription
CRKP infection7 daysCulture postitive results confirmed the infection of CRKP

Countries

China

Contacts

Primary ContactYing-zhi FANG, Master
fyz4817@126.com+86 57186006811

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026